0001562180-22-005637.txt : 20220708
0001562180-22-005637.hdr.sgml : 20220708
20220708175110
ACCESSION NUMBER: 0001562180-22-005637
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220706
FILED AS OF DATE: 20220708
DATE AS OF CHANGE: 20220708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Metzger Michael A
CENTRAL INDEX KEY: 0001507220
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37708
FILM NUMBER: 221075443
MAIL ADDRESS:
STREET 1: C/O SYNDAX PHARMACEUTICALS, INC.
STREET 2: 400 TOTTEN POND ROAD,
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001395937
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320162505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-419-1400
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-07-06
false
0001395937
Syndax Pharmaceuticals Inc
SNDX
0001507220
Metzger Michael A
C/O SYNDAX PHARMACEUTICALS, INC.
35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3
WALTHAM
MA
02451
true
true
false
false
Chief Executive Officer
Common Stock
2022-07-06
4
M
false
15009.00
6.38
A
32668.00
D
Common Stock
2022-07-06
4
S
false
15009.00
21.0745
D
17659.00
D
Common Stock
2022-07-07
4
M
false
100.00
6.38
A
17759.00
D
Common Stock
2022-07-07
4
S
false
100.00
21.00
D
17659.00
D
Stock Options (Right to buy)
6.38
2022-07-06
4
M
false
15009.00
0.00
D
2029-02-06
Common Stock
15009.00
0.00
D
Stock Options (Right to buy)
6.38
2022-07-07
4
M
false
100.00
0.00
D
2029-02-06
Common Stock
100.00
0.00
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 702,068 options to purchase shares of common stock that are vested and immediately exercisable and a total of 554,172 options to purchase shares of common stock that have not yet vested.
The sale prices ranged from $21.00 to $21.25.
This option vests periodically upon the Issuer achieving certain milestones.
/s/ Michael A. Metzger
2022-07-08